Triple-Negative Breast Cancer Prevention Vaccine

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

Evening Wire: Trump Lands Bipartisan Win Against Fraud & Clancy Holdout Juror Speaks | 9.17.26 10 min · 17 Sep 2026 · Morning Wire

Mackenzie Astin Meets World 59 min · 17 Sep 2026 · Pod Meets World

Jasmine Crockett Honoring Chris Brown Was WEIRD 24 min · 17 Sep 2026 · The Brett Cooper Show

The Fireball Friday Quiz (18.09.26) 3 min · 17 Sep 2026 · SEN Breakfast

Report any issue

Source

Recorded28 Oct 2021

Publisherfeeds.buzzsprout.com

Handlerec:1648305

Show notes

Cleveland Clinic recently opened a clinical trial to determine the maximum tolerated dose of a vaccine in patients with non-metastatic triple-negative breast cancer (TNBC). The breast cancer vaccine was invented and developed by Cleveland Clinic immunologist Vincent Tuohy, PhD, and his research team. Cleveland Clinic medical oncologist and principal investigator, G. Thomas Budd, MD, joins the Cancer Advances podcast to discuss the trial origins and what we are looking to accomplish.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in